Cerenia for Nausea During Administration of DTIC in Dogs

Description

DTIC is a common anti-neoplastic drug used for many tumor types. This drug is known to induce nausea or vomiting when administered to dogs as a long infusion. The goal of this study is to evaluate the efficacy of an established anti-nausea medication, Cerenia™ in controlling emesis developing from DTIC administration.

Inclusion Criteria

The study is available for any dog receiving DTIC as part of their cancer therapy.

Exclusion Criteria

Any dog with current vomiting or diarrhea.

Client Benefits

The owner is financially responsible for all tests that determine if the patient qualifies for the study. These tests may include initial specialty examination, x-rays, blood and urine tests.

The study will cover the cost of pretreatment antinausea medication, additional antinausea medication during the dacarbazine infusion if needed, and 80% of up to two dacarbazine chemotherapy treatments.

Contact Information

Kelly Reed, Oncology Liaison
Phone: (508) 887-4682